SCHEMBL27357767

SCHEMBL27357767

CCCCCCCCCOC1CCN(C(=O)OCC)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.44
▸ THRB P10828 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NOS3 P29474 1/20 0.40
▸ NOS2 P35228 1/20 0.40
▸ GBA2 Q9HCG7 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GNAI3 P08754 1/20 0.38
▸ GNAO1 P09471 1/20 0.38
▸ GNAI1 P63096 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ LIPC P11150 1/20 0.38
▸ LIPG Q9Y5X9 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21384260 0.81 LMNA (0.45) GAATHRBATML3MBTL1NOS3
SCHEMBL19833478 0.79 PIK3CD (0.42) —
SCHEMBL13107602 0.79 PRMT5 (0.46) ALDH1A1LIPCLIPGPDE4B
SCHEMBL27357675 0.79 GAA (0.43) GAATHRBATML3MBTL1NOS3
SCHEMBL9051469 0.77 SMN1; SMN2 (0.43) GAAL3MBTL1GBA2LMNAPOLB
SCHEMBL24348077 0.77 GAA (0.53) GAATHRBATML3MBTL1NOS3
SCHEMBL26465066 0.77 GAA (0.46) GAATHRBATML3MBTL1NOS3
SCHEMBL24943351 0.75 GNAI3 (0.56) L3MBTL1POLBGNAI3GNAO1GNAI1
SCHEMBL30744688 0.74 ALDH1A1 (0.47) GAATHRBATML3MBTL1NOS3
SCHEMBL24673636 0.74 HRH2 (0.41) ALDH1A1LMNASMN1; SMN2GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050742-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KRAS G12D VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2024-03-14 — — WO disclosed
Send feedback